Clinical Trial Update: Timed Release Tablet Prednisone in Polymyalgia Rheumatica [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluated timed release prednisone for polymyalgia rheumatica; status completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polymyalgia Rheumatica

Drugs mentioned

• timed release prednisone (prednisone)

Snippet

Sponsor: University Hospitals Bristol and Weston NHS Foundation Trust | Conditions: Polymyalgia Rheumatica | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2018-02-05